<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000367409"><TermName>iodine I 131 tositumomab</TermName><TermPronunciation>(I-oh-dine I 131 TAH-sih-TOO-moh-mab)</TermPronunciation><TermDefinition><DefinitionText>A drug used with another drug to treat certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Iodine I 131 tositumomab is a form of the monoclonal antibody tositumomab that is linked to the radioactive substance iodine I 131. It is a type of radioimmunoconjugate.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000711446" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;iodine I 131 tositumomab&quot;" language="en" id="_3"/><MediaLink ref="CDR0000711447" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;tositumomab con yodo 131&quot;" language="es" id="_4"/><SpanishTermName>tositumomab con yodo 131</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa con otro medicamento para tratar ciertos tipos de linfoma no Hodgkin de células B. También está en estudio para el tratamiento de otros tipos de cáncer. El tositumomab con yodo 131 es una forma del anticuerpo monoclonal tositumomab que se une a la sustancia radiactiva yodo 131. Es un tipo de radioinmunoconjugado.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2004-04-23</DateFirstPublished><DateLastModified>2011-08-17</DateLastModified></GlossaryTerm>
